Kyto Technology and Life Science, Inc

Ultragenyx Pharmaceutical Inc, based in Novato, is at the forefront of rare disease medicine, dedicated to advancing the rare disease community. With a commitment to progress and innovation, Ultragenyx is shaping the future of healthcare for those with rare diseases. Driven by a mission to propel the rare disease field forward, Ultragenyx Pharmaceutical Inc is a leader in developing treatments and therapies for those in need. Their focus on rare diseases underscores their dedication to improving the lives of patients and caregivers worldwide. Generated from their website's infomation

Alexza Pharmaceuticals is a pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The company's technology, the Staccato system, vaporizes unformulated drug compound to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. Alexza Pharmaceuticals has four product candidates in clinical development: AZ-001 (Staccato prochlorperazine) for the treatment of acute migraine headaches; AZ-002 (Staccato alprazolam) for the acute treatment of panic attacks associated with panic disorder; AZ-004 (Staccato loxapine) for the treatment of acute agitation in patients with schizophrenia; and AZ-003 (Staccato fentanyl) for the treatment of patients with acute pain. Alexza Pharmaceuticals is located in Palo Alto, Calif.

Central Admixture Pharmacy Services (CAPS) is the largest network of outsourcing admixture pharmacies in the United States, specializing in 503A and 503B compounded sterile preparations (CSPs). With a commitment to high-quality medications and patient safety, CAPS operates 21 regional pharmacies and two FDA-registered outsourcing facilities to meet customized and non-patient-specific compounding needs. Focused on improving operational efficiency, CAPS offers innovative solutions like the CAPSLink PN Ordering Software to reduce transcription errors and streamline order entry processes. The company prioritizes quality assurance through its cGMP Level Release Testing and comprehensive compliance program, ensuring reliable access to essential medications for patients. Generated from the website